Keep away from or Use Alternate Drug. Coadministration of apalutamide, a strong CYP3A4 inducer, with prescription drugs which can be CYP3A4 substrates may lead to lessen exposure to those medicines. Prevent or substitute another drug for these medicines when achievable. Examine for lack of therapeutic outcome if medication has to be coadministered.